RETRACTED: Choi et al. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease. Molecules 2021, 26, 3329.
- DOI
- 10.3390/molecules31142471
- Published
- 2026 Jul 15
- Container
- Molecules (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/molecules31142471,
title = {RETRACTED: Choi et al. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease. Molecules 2021, 26, 3329.},
author = {Choi YJ and Kim DW and Shin MJ and Yeo HJ and Yeo EJ and Lee LR and Song Y and Kim DS and Han KH and Park J and Lee KW and Park JK and Eum WS and Choi SY},
year = {2026},
journal = {Molecules (Basel, Switzerland)},
doi = {10.3390/molecules31142471},
url = {https://doi.org/10.3390/molecules31142471}
}RIS
TY - JOUR TI - RETRACTED: Choi et al. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease. Molecules 2021, 26, 3329. AU - Choi YJ AU - Kim DW AU - Shin MJ AU - Yeo HJ AU - Yeo EJ AU - Lee LR AU - Song Y AU - Kim DS AU - Han KH AU - Park J AU - Lee KW AU - Park JK AU - Eum WS AU - Choi SY PY - 2026 JO - Molecules (Basel, Switzerland) DO - 10.3390/molecules31142471 UR - https://doi.org/10.3390/molecules31142471 ER -
APA
YJ, C., DW, K., MJ, S., HJ, Y., EJ, Y., LR, L., Y, S., DS, K., KH, H., J, P., KW, L., JK, P., WS, E., & SY, C. (2026). RETRACTED: Choi et al. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease. Molecules 2021, 26, 3329.. Molecules (Basel, Switzerland). https://doi.org/10.3390/molecules31142471
Source records
- pubmed · retrieved 2026-09-26T21:11:33.354Z
- europe-pmc · retrieved 2026-09-26T21:11:33.363Z
- doaj · retrieved 2026-09-26T21:11:33.359Z